Jun. 3, 2020—People with cancer sickened by COVID-19 have a crude death rate of 13%, according to the largest series of data released thus far from a multinational perspective. The data on more than 900 patients also revealed cancer-specific factors associated with increased mortality.
Apr. 15, 2020—A multidisciplinary team of investigators at Vanderbilt University and Vanderbilt University Medical Center has received a program project grant from the National Cancer Institute to explore extracellular RNA in colorectal cancer.
Vanderbilt Bytes into Data Science: New programs in a revolutionary field will foster discovery, collaboration and learning across campus
Sep. 6, 2018—Data science likely will revolutionize a number of disciplines in the coming years. Yet Vanderbilt experts say we’ve barely reached the beginning stages of unlocking the full potential of data science—or understanding how to use it responsibly.
May. 14, 2018—A data science institute, new faculty and technical staff, and expanded educational offerings are the key investments recommended by the Data Science Visions Working Group.
Aug. 17, 2017—Provost and Vice Chancellor for Academic Affairs Susan R. Wente has named 20 faculty members to a new working group that will analyze the directions for new big data and data science initiatives.
Nov. 25, 2016—Nine Vanderbilt University faculty members have been elected fellows of the American Association for the Advancement of Science this year.
May. 19, 2016—A top Vanderbilt-Ingram Cancer Center (VICC) investigator recently met with Vice President Joe Biden regarding the National Cancer Moonshot Initiative, a major national program to identify, fund and accelerate the most promising research leading to cancer cures.
Mar. 10, 2016—Biomarker tests that help determine which patients may benefit from molecularly targeted therapies need better evidence and oversight to improve their effectiveness and availability, according to a study by the Institute of Medicine (IOM) of the National Academies of Sciences, Engineering, and Medicine.
Mar. 5, 2015—Two Vanderbilt-Ingram Cancer Center (VICC) leaders have been named to a panel of the Institute of Medicine (IOM) to help shape national policies on the use of biomarkers for targeted cancer therapies.